MENU

JANX Janux Therapeutics Forecast, Technical & Fundamental Analysis

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more

JANX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
JANX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

JANX is expected to report earnings to rise 21.49% to -47 cents per share on November 10

Janux Therapeutics JANX Stock Earnings Reports
Q3'26
Est.
$-0.47
Q1'26
Beat
by $0.18
Q4'25
Beat
by $0.11
Q3'25
Beat
by $0.23
Q2'25
Missed
by $0.09
The last earnings report on May 07 showed earnings per share of -38 cents, beating the estimate of -56 cents. With 288.72K shares outstanding, the current market capitalization sits at 1.18B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
109
Web
https://www.januxrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCVCX21.63N/A
N/A
JHancock Classic Value C
LAMQX27.60N/A
N/A
Lord Abbett Dividend Growth R2
UIVAX22.50N/A
N/A
Victory Value Institutional
VECRX23.69N/A
N/A
Virtus KAR Equity Income R6
RICBX67.81-0.42
-0.62%
American Funds Invmt Co of Amer R-2

JANX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with VIR. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-3.54%
VIR - JANX
39%
Loosely correlated
-3.31%
URGN - JANX
38%
Loosely correlated
+2.70%
ORMP - JANX
36%
Loosely correlated
-4.02%
VTGN - JANX
36%
Loosely correlated
-3.25%
AVBP - JANX
35%
Loosely correlated
-1.62%
More
Janux Therapeutics (JANX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com